催眠
发表于 2025-3-28 17:06:12
Inflammation and Epicardial Adipose Tissue in the Pathobiology of Atherogenesis and Neointimal Hyperective therapeutic interventions and preventive strategies. The basic and applied research have significantly advanced the understanding on the molecular pathology of CHDs and opened multiple translational avenues in the management. Despite the significant enhancement of knowledge in the underlying
Gourmet
发表于 2025-3-28 19:10:19
http://reply.papertrans.cn/19/1867/186698/186698_42.png
GNAT
发表于 2025-3-29 01:28:22
Obesity and Cardiovascular Disease: Impact of Resveratrol as a Therapeuticcongestive heart failure. Increased adiposity is the hallmark of this physiological alteration of the body in response to excess intake of energy rich food, and this condition has far reaching health consequences in humans. Adipose dysfunction develops over time leading to increased secretion of inf
auxiliary
发表于 2025-3-29 06:14:34
http://reply.papertrans.cn/19/1867/186698/186698_44.png
flimsy
发表于 2025-3-29 07:23:27
http://reply.papertrans.cn/19/1867/186698/186698_45.png
朴素
发表于 2025-3-29 14:16:31
Book 2020Cardiovascular Dysfunction in obesity (9 chapters). . .Theintent of this volume is to provide current and basic understanding of the biochemical mechanisms of obesity induced cardiovascular dysfunction that will be of value not only to cardiologists and other allied health professionals, but will a
详细目录
发表于 2025-3-29 18:33:21
Biochemistry of Cardiovascular Dysfunction in Obesity
预测
发表于 2025-3-29 19:43:29
http://reply.papertrans.cn/19/1867/186698/186698_48.png
CLIFF
发表于 2025-3-30 02:44:59
,Kosten- und Erlösartenrechnung, direct role of LXR agonist in various cardiovascular diseases like atherosclerosis, myocardial infarction, diabetic cardiomyopathy, cardiac hypertrophy, fibrosis. These accumulating evidences support that LXRs may represent a novel potential therapeutic target for various cardiovascular diseases.
一条卷发
发表于 2025-3-30 04:28:13
Olaf Plötner,Tyge -F. Kummer,Barbara Sieben modalities in obesity induced cardiovascular diseases. We review various NLRP3 inflammasome-targeted strategies and the evidence supporting the role of the NLRP3 inflammasome in obesity induced cardiovascular complications such as atherosclerosis, hypertension, myocardial infarction and adverse car